Clinical value of 12-lead electrocardiography to predict the long-term prognosis of gissi-1 patients  by Mauri, Francesco et al.
Myocardial Infarction
Clinical Value of 12-Lead Electrocardiography to
Predict the Long-Term Prognosis of GISSI-1 Patients
Francesco Mauri, MD,* Maria Grazia Franzosi, PHD,† Aldo Pietro Maggioni, MD,‡
Eugenio Santoro, MS,§ Luigi Santoro, MS§
Milan and Firenze, Italy
OBJECTIVES We evaluated the prognostic relevance of the extent of myocardial injury, as measured by a
standard electrocardiographic (ECG) method, on the patients’ long-term prognosis, its time
dependence and its relation to fibrinolytic therapy efficacy.
BACKGROUND Many clinical and instrumental variables influence the short- and long-term prognoses of
patients with acute myocardial infarction (MI). The extent of myocardial injury is relevant to
predict both the short-term prognosis and the benefit of fibrinolytic treatment.
METHODS In 8,731 patients with MI enrolled in the Gruppo Italiano per lo Studio della Sopravvivenza
nell’Infarto (GISSI-1) study, the number of ECG leads with ST-segment elevation was used
to define the extent of myocardial injury and four different severity groups: A, B, C and D,
with ST-segment elevation in two or three leads, four or five leads, six or seven leads and more
than eight leads, respectively.
RESULTS At 10 years, the mortality rates were 36.6%, 41.0%, 47.9% and 51.2% in groups A, B, C and
D, respectively. At 30 days, according to the extent of myocardial injury, the relative risk (RR)
of death was significantly higher for groups B, C and D, compared with group A (RR 1.19
and 95% confidence interval [CI] 1.06 to 1.34 for group B; RR 1.54 and 95% CI 1.31 to 1.80
for group C; RR 2.01 and 95% CI 1.69 to 2.39 for group D). At one-year follow-up, the RR
of death remained higher for groups C and D, whereas, subsequently, the extent of
myocardial injury did not influence the RR of death. At 10 years, the differences in fibrinolytic
treatment benefit between the four groups were similar to those at hospital discharge.
CONCLUSIONS At 10 years, the survival rate appears to be related to the extent of myocardial injury, as
evaluated by ST-segment elevation on the admission ECG. (J Am Coll Cardiol 2002;39:
1594–600) © 2002 by the American College of Cardiology Foundation
The substantial advances in the treatment of acute myocar-
dial infarction (MI) achieved in the last two decades can be
attributed mainly to a prompt and early recovery of optimal
infarct-related coronary artery flow by pharmacologic ther-
apy and/or mechanical intervention.
An early definition of the short-term prognosis is an
important step in the decision-making process of selecting
the best therapy. Lee et al. (1) have recently stated that the
prognosis of individual patients can be accurately estimated
through consideration of various characteristics, including
age, a medical history, the pathophysiologic presentation of
the infarction and medical treatment at hospital admission.
However, there is a lack of detailed measures of ST-
segment elevation and left ventricular function.
Among the many demographic, clinical and instrumental
variables that influence the short- and long-term prognoses
of acute MI, the extent of injury and left ventricular function
have significant relevance. The extent of injury can be
measured by different techniques, but standard electrocar-
diography (ECG) is the most widely available and the most
easily and promptly achievable method (2,3).
A method to assess the short-term prognostic significance
of the extent of myocardial injury, evaluated by standard
ECG at admission for acute MI, has been developed from
the Gruppo Italiano per lo Studio della Sopravvivenza
nell’Infarto (GISSI-1) study (4). This large, randomized
trial, including 11,712 patients with acute MI within 12 h
from the onset of symptoms, conducted between February
1984 and June 1985, showed the efficacy of streptokinase
versus standard therapy in reducing in-hospital mortality,
and thus began the thrombolytic era (5). The GISSI-1 study
even showed that the extent of myocardial injury, assessed as
the number of standard ECG leads with ST-segment eleva-
tion, was more relevant than the site in determining in-hospital
mortality and the efficacy of thrombolytic therapy (4).
The aim of the present study is to evaluate the time
dependence and long-term prognostic significance of the
same index of extent of myocardial injury and its correlation
with the benefit of thrombolytic therapy after 10 years.
METHODS
Study group. The GISSI-1 protocol has been fully de-
scribed elsewhere (5). In brief, 11,712 patients with MI who
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were admitted to the 176 participating coronary care units
were randomized to streptokinase (SK) or control within
12 h from the onset of symptoms.
The results of in-hospital mortality and one-year survival
have been previously published (5,6). The 10-year follow-up
results have also been published, tracing the vital status for
all randomized patients through the census offices of their
towns of residence by means of prepaid return-mail ques-
tionnaires. Information on death from any cause at the 10-year
follow-up was available for 10,889 (93%) of the 11,712 patients
originally randomized, with no significant differences between
SK-treated patients and control subjects (7).
For each patient, a standard ECG was obtained before
randomization and centrally analyzed. For the purpose of
the present study, all patients with a previous MI, bundle
branch block and an unconfirmed diagnosis were excluded
from the analysis. Using these criteria, 8,731 patients were
selected: 6,976 (79.9%) were male; 5,789 (52.5%) were65
years of age; 2,055 (23.5%) were between 66 and 75 years of
age; 885 (10.1%) were 75 years old; 4,372 (50.07%) were
assigned to routine treatment; and 4,359 (49.93%) were
treated with 1.5 million units of SK. The demographic
characteristics were similar to those of the whole population
enrolled in the GISSI-1 trial.
ECG analysis. All ECGs were reviewed centrally by two
clinicians who had no knowledge of the randomized treat-
ment or the patients’ outcome, and the following information
was gathered: the presence of ST-segment elevation, ST-
segment depression and Q-waves 0.03 s in each lead, the
presence of major conduction disturbances and the infarct site.
The criteria to classify the different infarct locations have
been previously described (4): anterior MI represents
Q-waves and/or ST-segment elevation 2 mm in leads V1
through V6, I and aVL; inferior and/or posterior MI
represents Q-waves 0.030 s and voltage 1/4 of the
R-wave in lead aVF and/or 1-mm ST-segment elevation in
leads II, III and aVF; R  S in lead V1 or V2, compared
with a previous ECG, or with a lower voltage in the
precordial leads that followed; lateral MI represents
Q-waves 0.030 s and voltage 1/4 of the R-wave in
isolated leads I and aVL and/or isolated leads V5 and V6;
and multiple sites represent concomitant signs of anterior or
lateral plus inferior MI. The criteria to define the different
myocardial injury sizes, according to the presence of ST-
segment elevation 1 mm in the limb leads and 2 mm in
the precordial leads, have been previously reported. In the
presence of inferior MI, any precordial ST-segment depres-
sion was considered as indicative of myocardial injury at the
opposite location and counted as ST-segment elevation if
2 mm. The number of leads with ST-segment elevation
was used to classify four groups: patients in group A (small
myocardial injury) had ST-segment elevation in 2 to 3 leads;
patients with ST-segment elevation in 4 or 5 leads com-
prised group B (modest injury); those with ST-segment
elevation in 6 or 7 leads comprised group C (large injury);
and those with  8 leads with ST-segment elevation
comprised group D (extensive injury).
Statistical analysis. PROGNOSTIC SIGNIFICANCE OF THE
EXTENT OF MYOCARDIAL INJURY. The association between
the extent of myocardial injury and other baseline charac-
teristics was analyzed by using the chi-square test. For
survival analysis, the Kaplan-Meier method was used, and
Table 1. Main Demographic and Clinical Features of the Study Group
Demographic and
Clinical Variables
Group A
(n  3,539)
Group B
(n  2,198)
Group C
(n  1,631)
Group D
(n  1,363) p Value
Gender (male) 2,885 (81.5) 1,729 (78.7) 1,256 (77.1) 1,106 (81.1) 0.001
Age (yrs)
65 2,450 (69.2) 1,445 (65.7) 1,027 (63.0) 867 (63.6) 0.001
65–75 783 (22.1) 517 (23.5) 414 (25.4) 341 (25.0)
75 305 (8.6) 236 (10.7) 190 (11.6) 154 (11.3)
Delay from onset of symptoms (h)
0–3 1,899 (53.7) 1,111 (50.5) 835 (51.2) 736 (54.0) 0.08
3–6 1,074 (30.5) 715 (32.5) 501 (30.7) 431 (15.8)
6–9 388 (10.9) 257 (11.7) 197 (12.1) 144 (10.6)
9–12 176 (5.0) 111 (5.0) 93 (5.7) 50 (3.7)
Killip class
I 2,749 (77.7) 1,599 (72.7) 1,082 (66.3) 830 (60.9) 0.001
II 642 (18.1) 480 (21.8) 420 (25.7) 419 (30.7)
III 73 (2.1) 67 (3.1) 83 (5.1) 60 (4.4)
IV 62 (1.7) 42 (1.9) 40 (2.4) 51 (3.7)
Control subjects 1,780 (50.3) 1,100 (50.0) 807 (49.5) 685 (50.3) 0.96
Streptokinase-treated patients 1,759 (49.7) 1,098 (50.0) 824 (50.5) 678 (49.7)
Data are presented as the number (%) of patients.
Abbreviations and Acronyms
CI  confidence interval
ECG  electrocardiogram or electrocardiographic
GISSI  Gruppo Italiano per lo Studio della
Sopravvivenza nell’Infarto trial
MI  myocardial infarction
RR  relative risk
SK  streptokinase
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the p value was determined by the log-rank test (8).
Multivariate analysis, according to the Cox model, was used
to estimate the relative risk (RR) and the 95% confidence
interval (CI); all variables with a statistically significant
difference on the univariate analysis were included in the
model. Data were analyzed according to the intention-to-
treat principle. All p values are double-sided; values of p 
0.05 were considered as conventionally significant.
To test the time dependence of the RR for the extent of
myocardial injury over the 10-year period, a test for the
proportional hazards assumption was performed by using
multivariate analysis according to the Cox model and including
the extent of myocardial injury as the time-dependent covariate
(9). Such analysis was also adjusted for confounding variables
(e.g., age, gender, time from onset of symptoms, Killip class,
systolic blood pressure, randomized treatment).
EFFECT OF THROMBOLYTIC TREATMENT AMONG THE
GROUPS WITH DIFFERENT EXTENTS OF MYOCARDIAL
INJURY. The modified Mantel-Haenszel method (10,11)
was used to calculate univariate estimates of the propor-
tional treatment effects among the four different groups of
the extent of myocardial injury.
To ascertain the heterogeneity of the effect of thrombo-
lytic treatment after 10 years among the groups with
different extents of myocardial injury, the Cox regression
model, including age, gender, time from symptom onset,
Killip class and systolic blood pressure, was used. The
improvement, in terms of the goodness-of-fit obtained by
comparing a model including only the main effects with a
model also including interaction variables, was measured by
means of the likelihood ratio test, which has an asyntotic
chi-square distribution. To make some allowance for the
effects of multiple comparisons, values of p  0.01 were
considered as conventionally significant for this analysis.
RESULTS
Among the 8,731 patients evaluated in this study, informa-
tion on vital status after 10 years was obtained for 8,093
patients (92.6%); this figure is similar to that observed for
the whole population of the GISSI-1 trial (93%), and, like
the main trial, a loss of information was equally distributed
among the four groups with different extents of myocardial
injury (6.8% of patients in group A; 7.4% in group B; 7.8%
in group C; and 7.4% in group D).
The distribution of demographic characteristics and the
delays from the onset of symptoms were not balanced
among the four different groups. Patients in groups C and D
were older, with a higher Killip class, whereas groups B and
C had more females (Table 1).
Of the 8,731 patients, 7,759 (88.9%) were discharged
alive from the hospital. The in-hospital mortality was
slightly lower than that of the whole population of the
GISSI-1 trial, as patients with left bundle branch block and
with ST-segment depression, which are associated with a
significantly worse prognosis, were excluded from the
present study (12,13).
Survival according to the extent of myocardial injury. As
previously described (4), in-hospital mortality was signifi-
cantly different among the four groups with myocardial
injury: 6.5% in group A, 9.6% in group B, 14.3% in group
C and 21.7% in group D. The mortality rate was slightly
higher after 30 days and was still significantly different
Figure 1. Ten-year survival curves for the four groups with different infarct sizes. The numbers near to the lines refer to electrocardiographic leads with
ST-segment elevation.
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among the groups. At 10 years, the estimated mortality
rates, as evaluated by survival curves, were 36.6% in group
A, 41.0% in group B, 47.9% in group C and 51.2% in group
D (Fig. 1). The curves indicate that the difference in survival
of the four different groups of patients is still significant at
10 years (p  0.0001 by the log-rank test).
Influence of the extent of myocardial injury on long-term
prognosis. As described in the Methods section, one of the
aims of this study was to test the time dependence of the RR
of death, according to the extent of myocardial injury during
the 10 years after the MI. The test for the proportional
hazards assumption (p  0.0001) suggests that the RR of
death for the extent of myocardial injury is not constant but
varies over time. For this reason, we calculated the adjusted
RR of death at 30 days after MI and for each year of the
subsequent 10 years (based on the number of survivors at
each previous year) for the four groups, taking patients with
small extent of myocardial injury as the reference group and
considering the extent of myocardial injury as the time-
dependent variable. At 30 days after the index event, the risk
of death was significantly higher in groups B (RR 1.19, 95%
CI 1.06 to 1.34), C (RR 1.54, 95% CI 1.31 to 1.80) and D
(RR 2.01, 95% CI 1.69 to 2.39), compared with group A.
At one year, the risk of death was significantly higher in
groups C and D (1.25 and 1.32, respectively), although
slightly different when compared with that at 30 days. After
the first year from the index event, the extent of myocardial
injury did not seem to further influence the long-term
prognosis, as no significant differences in the risk of death at
5 and 10 years were observed between the four groups.
Figure 2 shows the adjusted RRs of death at 30 days and 1,
5 and 10 years after MI. A different representation of the
same results is provided in Table 2, which shows the
mortality rates of the four groups, calculated for survivors at
each of the follow-up periods.
Effect of fibrinolysis in the groups with different extents
of myocardial injury. The difference in survival achieved
by in-hospital SK treatment was still significant at the
10-year follow-up (p  0.02 by the log-rank test). The
estimated cumulative 10-year mortality rate was 45.0% for
the 5,860 patients allocated to thrombolytic therapy and
46.9% for the 5,852 allocated to the control group, corre-
sponding to an absolute benefit of 19 lives saved for every
1,000 patients treated with fibrinolytic therapy (7). As for
the benefit distribution among the groups with different
extents of injury, long-term survival data are symmetrical
with those observed at hospital discharge (Fig. 3). The
chi-square test for heterogeneity on 3 degrees of freedom
was 6.99 (p 0.03), suggesting the presence of a qualitative
interaction between the effect of fibrinolytic treatment and
the different extents of myocardial injury. In other words,
the direction of the effect is maintained in all the four
groups, but the size of the effect remains statistically
significant only in those with a larger extent of injury. At
hospital discharge, the difference in favor of SK was present
in all the subgroups, but reached statistical significance only
in patients with modest (group B), large (group C) or
extensive (group D) myocardial injury. The lack of a
significant benefit observed at hospital discharge for group
A, with small infarcts, did not change (Table 3) at 10 years.
Figure 2. Plots of relative risk (RR) for the three groups with larger extents
of myocardial injury versus the group with the smaller extent of injury over
the different periods of follow-up.
Table 2. Mortality Rates for Study Patients at the Different Periods of Follow-Up
30 Days 1 Year 5 Years 10 Years
Group A 238/3,539 (6.72) [14] 140/3,287 (4.26) [20] 355/3,128 (11.35) [210] 495/2,562 (19.32) [—]
Group B 216/2,198 (9.83) [8] 94/1,974 (4.76) [14] 234/1,866 (12.54) [140] 307/1491 (20.59) [2]
Group C 242/1,631 (14.84) [6] 85/1,383 (6.15) [12] 184/1,286 (14.31) [110] 227/992 (22.88) [—]
Group D 308/1,363 (22.60) [11] 78/1,044 (7.47) [6] 128/961 (13.32) [85] 151/747 (20.21) [—]
Data are presented as the number of deaths per total number of patients in the group (percentage of patients) [number of patients
lost at follow-up].
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DISCUSSION
Our study shows that the simple method of standard ECG
allows a good evaluation of the extent of myocardial injury,
providing a good prognostic index for patients with acute
MI in the short- and long-term periods. Accordingly, a
concise reflection on some points appears appropriate.
Influence of the extent of myocardial injury on long-term
prognosis. First of all, the remarkable advances in the
quality and efficacy of the recent methods of pharmacologic
coronary reperfusion have improved the short-term prog-
nosis of patients with acute MI (14). However, the mortality
rate remains high, as the expected mortality rate per year for
patients between 51 and 59 years old, with no signs of
ischemic heart disease, is 2.93% (95% CI 2.05 to 4.18),
according to Rosengren et al. (15), whereas the mortality
rate for the whole GISSI-1 population mortality is 7.3% in
the first year after hospital discharge and 4.1% per year from
the second to the tenth year of follow-up. However, it is
well known that the risk of death varies among patients with
different demographic and clinical data or instrumental
features and is related to the effectiveness and early admin-
istration of therapy. Then, it is crucial to identify at hospital
Figure 3. Survival curves for patients included in the four groups with different extents of myocardial injury and different treatments. C  control; SK 
streptokinase.
Table 3. Estimated Mortality and Absolute Benefit of Streptokinase Treatment According to Extent of Infarct
Hospital Discharge 10-Year Follow-Up
Randomized
Patients (n)
Mortality
(%)
p
Value
Absolute Benefit
per 1,000 (95% CI)
Estimated
Mortality*
(%)
p
Value†
Absolute Benefit
per 1,000 (SD)SK C SK C SK C
Overall 4,359 4,372 9.7 12.5 0.005 28 (14–41) 40.9 43.3 0.011 24 (11)
Infarct extent
2 or 3 leads 1,759 1,780 6.1 6.9 NS 8 (9–24) 36.5 36.9 NS 4 (17)
4 or 5 leads 1,098 1,100 7.7 11.5 0.005 37 (12–62) 40.6 41.3 NS 7 (22)
6 or 7 leads 802 807 12.1 16.6 0.01 45 (11–79) 45.6 50.2 0.05 46 (26)
8 or 9 leads 678 685 19.5 23.9 0.05 45 (1–88) 47.2 55.0 0.004 78 (28)
*The 10-year estimated mortality values are derived from the life-tables. †By the log-rank test.
C  control subjects; CI  confidence interval; NS  not significant; SD  standard deviation; SK  streptokinase.
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admission those at higher risk of death, in order to select the
best strategy (fibrinolysis or percutaneous transluminal cor-
onary angioplasty, or both) to achieve the optimal myocar-
dial salvage in the shortest time.
Lee et al. (1) have defined an accurate formula based on
the demographic and clinical data observed at hospital
admission, in order to calculate the probability of death
within 30 days. They advocate the importance of the
availability of a simple method to define the extent of the
ischemic injury in progress.
The prognostic relevance of the extent of myocardial
injury, as evaluated by the number of standard ECG leads
with ST-segment elevation, has been previously emphasized
for the in-hospital period by our group (4) and other
investigators (16,17). Subsequently Hathaway et al. (18)
defined the relationship between ST-segment deviation, in
whichever direction, and mortality. More recently, Morrow
et al. (19) have included the anterior location of ST-
segment elevation among the 10 most important variables
useful to build up a convenient bedside clinical score for MI
risk assessment at presentation. The information is perfectly
consistent with our previously reported results (4): the
anterior MI site is usually associated with a larger extent of
injury, as evaluated by standard ECG. In our previous study,
we showed that in the group with anterior infarcts, there
was a confluence of patients with very different extents of
myocardial injury. The extent of injury varied from 2 or 3
leads in 4.6% of patients to 8 or 9 leads in30% of patients.
The mortality rate of patients with a smaller anterior MI
similar to that observed in patients with 2 or 3 leads in the
inferior site, validating the hypothesis that the size of
myocardial injury is more relevant than its site in predicting
the in-hospital outcome. The present study indicates that
the extent of myocardial tissue under jeopardy at hospital
admission also influences the long-term prognosis.
The second remarkable point is derived from the obser-
vation that the four survival curves mainly diverge in the first
period of observation, and the survival difference is sustained
up to 10 years (Fig. 1). In addition, Figure 4, showing the
four survival curves for patients discharged alive from
hospital, clearly shows that there is a divergence during the
first year, and then the slopes become similar. The RR plot
in Figure 2 confirms that at one year, the RR of death from
MI is significantly higher for patients with a larger extent of
myocardial injury. As the first month and, at the most, the
first year are the critical periods, it is clinically important to
have available an index of the extent of injury that can be
easily derivable from the standard ECG and widely and
promptly usable not only in the coronary care unit but also
in the mobile unit assisting the patient at the very first
contact (e.g., at home, in the office or even on the road).
The availability of information on the extent of myocardial
injury could allow us to triage patients to the most appro-
priate level of care in hospitals with different therapeutic
facilities.
Effect of fibrinolysis in the groups with different extents
of myocardial injury. The third point hinges on the fact
that, once again, the results of this study prove that the
larger the extent of myocardial injury, the better is the
benefit from thrombolytic therapy in terms of long-term
survival. Rentrop et al. (20) proposed, for the first time, the
hypothesis that the benefit of fibrinolytic therapy depends
Figure 4. Survival curves for patients with different extents of myocardial injury and discharged alive from the hospital.
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on the extent of jeopardized myocardium and on the delay
between the onset of symptoms and drug administration.
Their hypothesis concerned the final extent of myocardial
infarct. Many studies have subsequently confirmed the
consistency of this hypothesis, which can be demonstrated
by the mortality rate, starting from the in-hospital period up
to 10 years, as well as the survival rate of patients with a
larger myocardial injury size, as seen in the present study.
The observation can be assumed as an incentive to increase
the efforts to achieve in the shortest possible time the best
reperfusion therapeutic approach in these patients at high
risk, not as an indication to select patients for thrombolytic
therapy, given the fact that in terms of myocardial salvage,
a positive effect can be achieved in smaller infarcts as well.
Study limitations. The proposed method of evaluation
does not seem to be as precise as the one evaluated by
Aldrich et al. (16), which is nevertheless more elaborate,
suggesting a different approach for anterior and inferior
myocardial sites, and it requires the application of a math-
ematical formula, so without a calculator, which is not
always at hand, it may be difficult to use.
Moreover, the method proposed cannot be applied to
one-fourth of the whole population of patients with acute
MI with ST-segment depression, left bundle branch block
and a previous MI (21), nor probably to patients admitted
after 12 h, due to the spontaneous regression of ST-segment
elevation, especially when spontaneous reperfusion occurs.
Finally, the different results observed after thrombolytic
treatment must be considered as a result of subgroup
analysis, with all of the consequent limitations. They cannot
be considered as criteria for not treating patients with
smaller infarcts. The only real and important conclusion
that can be drawn from the evaluation reported here is that
patients with a larger extent of myocardial injury must be
treated with the most effective and quickest reperfusion
method to achieve survival.
Conclusions. Among the many demographic and clinical
variables that influence the prognosis of patients with MI, from
the decision-making point of view, only a few can be useful to
define the best therapeutic strategy that can significantly
improve the patient’s prognosis. The extent of myocardial
injury is probably the most important; this can be immediately
and simply established by standard ECG, which has a valid
albeit not anatomically precise prognostic value.
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